Patients with chronic rhinosinusitis with nasal polyps experienced improved sleep and functioning after 52 weeks of treatment with dupilumab, according to research published in The Journal of Allergy and Clinical Immunology: In Practice.
These improvements in turn improved health-related quality of life, William Busse, MD, honorary associate and fellow in the department of medicine, division of allergy, pulmonary and critical care at University of Wisconsin School of Medicine and Public Health, and colleagues wrote.
The randomized, placebo-controlled phase 3 SINUS-24 and SINUS-52 studies showed